Navigation Links
Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting
Date:9/27/2010

Newtown, PA, September 27, 2010 Onconova Therapeutics, Inc. is presenting new data in five posters and an oral presentation this week summarizing several studies with the company's radioprotectant Ex-RAD at the 56th Annual Meeting of the Radiation Research Society (RRS), September 25-29 in Maui, Hawaii. In vivo studies show that Ex-RAD, upon oral administration, produced a significant increase in survival versus placebo-treated groups in mice exposed to lethal whole body irradiation (WBI), for both prophylactic pre-treatment and mitigation post-treatment. Ex-RAD is the only known oral radioprotectant that has shown such activity in animal model systems.

Collectively, these presentations demonstrate the ability of Ex-RAD to provide radioprotective benefit by injection and oral delivery, an in-depth understanding of the kinetics and metabolism of Ex-RAD, and radioprotective benefit to human bone marrow, as well as the gastrointestinal and hematopoietic systems in mice.

Onconova, a biopharmaceutical company developing novel chemical entities to treat cancer and protect normal cells, is developing Ex-RAD, a novel radioprotectant with potential utility in bio-defense or bio-terrorism, which could prove useful as a prophylactic agent for first-responder protection from the harmful effects of radiation from nuclear accidents or weapons of mass destruction (WMD).

These presentations result from an on-going Onconova collaboration among investigators at a number of institutions: AFRRI, (The Armed Forces Radiobiology Research Institute) a part of the Uniformed Services University of the Health Sciences (USUHS); Georgetown University, Department of Biochemistry and Molecular & Cellular Biology; Long Island University, Arnold & Marie Schwartz College of Pharmacy; and the Department of Oncological Sciences, Mt. Sinai School of Medicine.

Summary of Oral Ex-RAD Findings

The results from a prophylactic radioprotecti
'/>"/>

Contact: Katrhyn Morris
kathryn@proncall.com
845-635-9828
PR on Call
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension
2. Study says therapeutics for trauma patients may not be effective due to an infection
3. Cambridge Healthtech Announces Its Inaugural Encouraging Development of Therapeutics for Neglected Diseases Conference
4. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
5. ACS Webinar focuses on drug discovery process for small molecule therapeutics
6. Talecris Biotherapeutics Hires Nimish Shah as Vice President, Federal Government Relations
7. US Patent Granted To Chrono Therapeutics Inc. For Its Chrono-Pharmacological Drug Delivery Systems And Applications
8. JDP Therapeutics, Inc. Appoints Christopher M. Cashman to Board of Directors
9. Moffitt Cancer Center and GLG Pharma, LLC sign licensing agreement to develop the next generation of targeted anti-cancer therapeutics
10. Moffitt Cancer Center and GLG Pharma LLC sign licensing agreement to develop the next generation of targeted anti-cancer therapeutics
11. FAB-HOMES™ Presents First Passive House Collection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2015)... ... ... "I have personally had three knee-replacement surgeries on the same knee, all ... up with this idea so that I could not only support my knee comfortable ... BUDDY to comfortably and safely support the knee while recovering from surgery or injury. ...
(Date:9/4/2015)... (PRWEB) , ... September 05, 2015 , ... Paradise ... from China for an exclusive, one-night exhibition of their work at Paradise Valley Community ... on Friday, September 18, from 6-9 pm. The artists will be on hand to ...
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... communities, is launching a charity effort to provide for the family of Grace, ... an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – the inability ...
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of mind is ... is quite common. Mold can grow anywhere - on carpet, clothing, food, paper, and ... excessive moisture and water in the home is key to preventing mold growth, which ...
Breaking Medicine News(10 mins):Health News:InventHelp Inventor Develops Therapeutic Knee Support (PHO-2061) 2Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4
... a new vaccine to prevent human papillomavirus (HPV) would ... cancer from the sexually transmitted infection did not increase ... new Florida State University study. Mary Gerend, assistant ... FSU College of Medicine, and Jessica Barley, a 2008 ...
... Inc. (Nasdaq: LCAV ), a leading provider of laser vision correction ... all six of its Board,s nominees to its Board of Directors, each for ... , William F. Bahl, Co-Founder ... John H. Gutfreund, President of Gutfreund & Co. Inc. , ...
... ... National Smile Month, and the Hispanic Dental Association (HDA), Oral Health America, and participating ... not to forget their toothbrushes on summer vacation. National Smile Month promotes the ... Brushing teeth twice a day with fluoride toothpaste , ...
... ... manufacturer and distributor of automated blood pressure monitors and health testing ... America,s Health Insurance Plans (AHIP) Institute 2009 Conference. The Conference will ... June 3 - 5, 2009. Lifeclinic will be located at the ...
... 2 /PRNewswire-Asia/ -- During a press conference,announcing the results ... Kong, Ms.,Ingrid Kan, Accredited Dietician of St. Teresa,s Hospital, ... issues among toddlers, including nutritional,deficiencies leading to impeded language ... also stated that many,parents do not emphasize enough the ...
... , , Approval for Antibiotic Delivered in DUPLEX Delivery ... Braun Medical Inc. (B. Braun), a leader in infusion therapy and ... (FDA) approval for 2g Cefazolin for Injection USP and ... . , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) , ...
Cached Medicine News:Health News:Study: Benefit to women not enough to sway men to get HPV vaccine 2Health News:Study: Benefit to women not enough to sway men to get HPV vaccine 3Health News:LCA-Vision Reports on Annual Meeting of Stockholders 2Health News:LCA-Vision Reports on Annual Meeting of Stockholders 3Health News:LCA-Vision Reports on Annual Meeting of Stockholders 4Health News:Hispanic Dental Association and Oral Health America Celebrate National Smile Month, June 1-30 2Health News:Lifeclinic International, Exhibiting its LC500 Health Station With OptumHealth at the America's Health Insurance Plans (AHIP) Institute 2009 Conference 2Health News:Lifeclinic International, Exhibiting its LC500 Health Station With OptumHealth at the America's Health Insurance Plans (AHIP) Institute 2009 Conference 3Health News:Diet, Purity of Food Source Could be Keys to Improving Health of Hong Kong Toddlers 2Health News:Diet, Purity of Food Source Could be Keys to Improving Health of Hong Kong Toddlers 3Health News:B. Braun Anticipates Becoming First to Deliver FDA Approved 2g Cefazolin 2Health News:B. Braun Anticipates Becoming First to Deliver FDA Approved 2g Cefazolin 3
(Date:9/4/2015)... -- Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi , ... September 10, 2015. DATE: Thursday, September 10, ... This will be a live, ... the company questions in real-time - both in the ... booth." If attendees are not able to join the ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Pharmacovigilance (London, UK ... offering. Understanding PhV today - the ... working in Drug safety. This course ... with pharmacovigilance. New entrants as well as experienced ...
(Date:9/4/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... of new cancer therapies, today announced its financial results ... provided an overview of recent Company highlights and expected ... host a business update conference call and live webcast ...
Breaking Medicine Technology:Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8
... at Self Regional Healthcare,s South Carolina Spine Center in ... of spinal conditions in its new advanced surgical operating ... Already recognized by leading health care ratings organization HealthGrades ... its commitment to advanced spinal care by becoming the ...
... YORK, Oct. 6 Pfizer (NYSE: ... its acquisition of FoldRx Pharmaceuticals, Inc., a privately held ... FoldRx Pharmaceuticals, Inc. is now a wholly owned subsidiary ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO) Pfizer Inc: ...
Cached Medicine Technology:Self Regional Healthcare Becomes First in the Southeast to Treat Spine Patients Using Advanced Integrated Operating Room Technology From Brainlab 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: